Cite
HARVARD Citation
Ades, P. (n.d.). Effect of alirocumab dose increase on LDL-lowering and lipid goal attainment. Coronary artery disease. 28 (3), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ades, P. (n.d.). Effect of alirocumab dose increase on LDL-lowering and lipid goal attainment. Coronary artery disease. 28 (3), p. . [Online].